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Note that S-cMg com , measured by ISE, needs to be corrected for the water displacement effect by the serum proteins when it is related to S-cMg. Furthermore, our approach assumes, for example, that the added phosphate (1.09 mmol/L) complexes the same amount of magnesium as the phosphate already present (mean, 1.09 mmol/L). This is justified because the functions calculated from the theoretical complexation constants are quasi-linear in the range we investigated (8) . In addition, complexation decreased proportionally when the concentrations of added complexants were only one-half of the concentrations of the original complexants.
On the other hand, when reliable values for S-cMg com and UF-cMg become available, we should be able to calculate S-cMg 2ϩ by subtracting S-cMg com and serum protein-bound magnesium (S-cMg pb ) from S-cMg (Note: S-cMg pb ϭ S-cMg Ϫ UF-cMg). If S-cMg 2ϩ correlates reasonably well with S-cMg, a practical standardization approach for S-cMg 2ϩ , based on S-cMg, should be possible. To investigate this, we measured the S-cMg and UF-cMg in 12 serum samples with an ion chromatography reference method (11) ; for S-cMg pb , we found a value of 31.5% (Ϯ 1.6%, 95% confidence interval), which is in good agreement with the 33.7% reported by Speich et al. (2) (Note: Like S-cMg com , UF-cMg must also be corrected). According to the above proposal, our data would yield a calculated value of 58.1% for S-cMg 2ϩ . We measured S-cMg 2ϩ with the AVL 988-4 and found an excellent correlation between S-cMg and pH-normalized S-cMg 2ϩ in a panel of 57 serum samples (r ϭ 0.9223; P Ͻ0.001; S-cMg range, 0.74 -0.92 mmol/L).
From these preliminary results, we concluded that standardization of S-cMg 2ϩ on the basis of S-cMg is a realistic option. We will undertake additional experiments to substantiate our observation that, for serum samples from apparently healthy do-nors, S-cMg 2ϩ accounts for ϳ58% of S-cMg (the fraction is usually assumed to be 65%).
An IgM Paraprotein Causing a Falsely Low Result in an Enzymatic Assay for Acetaminophen
To the Editor: Since the development of enzymatic assays for acetaminophen in the early 1980s, their use has rapidly become widespread (1) . Their advantages of speed and ready automation have ensured that Ͼ95% of laboratories submitting to a external quality assessment scheme now use this method (M.A. Thomas, personal communication). Given this fact and the absolute dependence on the laboratory result for clinical decision making, it is important to be aware of any possible discrepancies associated with this technique. I therefore report here a case of a man with an IgM monoclonal gammopathy who ingested acetaminophen and whose subsequent serum acetaminophen concentration was falsely low on enzymatic assay.
When we were investigating a 77year-old man who was admitted after a cerebrovascular accident in 1990, we noted that he had an IgM monoclonal component of 5 g/L. In the absence of any other clinical or laboratory evidence of a hematological dyscrasia, a diagnosis of monoclonal gammopathy of unknown significance (MGUS) was made. On a subsequent occasion, he was admitted to the Accident and Emergency Department after he ingested 100 tablets of acetaminophen 18 h previously. Samples were sent for acetaminophen analysis; however, in view of his history, N-acetylcysteine was administered before the results became available. Over succeeding days the patient's alanine aminotransferase peaked at 2515 U/L, his bilirubin peaked at 40 mol/L, and his international normalized ratio peaked at 1.3. The concentration of his IgM monoclonal component was 7 g/L. His IgG was slightly low at 6.3 g/L (reference range, 7.0 -19.0 g/L), but his IgA [1.53 g/L (reference range, 0.90 -4.50 g/L)] and blood film were normal. After 6 days, he was discharged to a psychiatric ward Clinical Chemistry 45, No. 1, 1999 and subsequently made a full recovery.
We assayed the serum acetaminophen using a commercially available enzymatic kit (Cambridge Life Sciences) that had been adapted for use on a Cobas Fara II (Roche Diagnostic Systems Ltd.) and determined that his serum acetaminophen concentration was 53 mg/L. However, we noted that the absorbance after the first stage of the assay, which involves addition of sample to reconstituted enzyme reagent, was 0.145 absorbance units. This greatly exceeded the concentrations seen routinely with other sera (Ͻ0.01 absorbance unit). Furthermore, the measured values did not change in a linear fashion when the sample itself was diluted. When a drop of serum was added to water (the Sia water test) (2), a flocculent precipitate formed. The acetaminophen concentration determined by HPLC on a Spherisorb column using an aqueous solution of n-propanol was 86 mg/L.
In our automated enzymatic assay for acetaminophen, samples are diluted with water and then mixed with reconstituted enzyme reagent (aryl acylamidase in Tris-HCl buffer, pH 8.6). The absorbance at 615 nm is then measured. After incubation, the color reagent (o-cresol in ammoniacal copper sulfate) is added, and a final absorbance measurement is taken after another 3 min. The acetaminophen concentration is calculated from the difference between the two absorbance readings. It appears that addition of our patient's serum to the aqueous diluent or the enzyme reagent caused precipitation of his IgM monoclonal paraprotein in a manner akin to the Sia test. Because the Cobas Fara is configured in such a way that dilution alone should not alter the measured absorbance and because the final measured acetaminophen was actually lower than the true value determined by HPLC, the precipitate may well have partially redissolved in the subsequent more alkaline medium of the color reagent.
Several authors have recognized that precipitation of paraproteins may cause potentially unrecognized interference in a range of different assays. The interference in phosphate (3) and calcium (4) determinations has been attributed to precipitation in an acid medium. In contrast, spuriously high hemoglobin values have been reported when a monomeric IgM paraprotein precipitated on addition to a lysing reagent with a pH of 9.2 (5) . Above all, however, as highlighted by Tokmakjian et al. (6) in their discussion of a patient with pseudohypoglycemia and hypophosphatemia, paraproteins precipitate in distilled water. This, of course, is the very property that was used previously for their detection (Sia water test) (2) . They then recognized that the charge and concentration of the monoclonal component influenced whether the Sia test was positive. It seems likely, then, that different paraproteins will precipitate at different pH values and, therefore, that few if any laboratory investigations are immune from this interference.
Certainly this study demonstrates that if a monoclonal gammopathy is present, then acetaminophen should be added to the list of analytes whose results must be interpreted with care.
Whether the presence of a paraprotein increases or decreases the measured results will depend on whether a sample blank is included. The latter eventuality, that of a spuriously low reading, is of particular concern because potentially life-saving therapy with N-acetylcysteine could be withheld on the basis of erroneous laboratory findings.
If laboratories measure acetaminophen with an enzymatic assay, they are advised to ensure that their method can detect the increase in absorbance that will occur if a paraprotein precipitates on dilution or addition of reagents. I thank B.P. Spragg and the staff of the Welsh National Poisons Unit Laboratories who provided the HPLC determination of acetaminophen.
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